OVID
Ovid Therapeutics Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.17
+0.93%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1089.09x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.02x
- Price / sales
- 267.72x
- Price / cash flow
- -7.74x
Enterprise value
- Enterprise value
- $319.3M
- EV / sales
- 201.70x
- EV / EBITDA
- -8.96x
- EV / EBIT
- -5.47x
- Market cap
- $423.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026